Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FATE |
---|---|---|
09:32 ET | 36480 | 3.63 |
09:34 ET | 7082 | 3.63 |
09:36 ET | 6559 | 3.71 |
09:38 ET | 7841 | 3.7 |
09:39 ET | 1777 | 3.72 |
09:41 ET | 1629 | 3.745 |
09:43 ET | 6595 | 3.71 |
09:45 ET | 7420 | 3.72 |
09:48 ET | 10603 | 3.705 |
09:50 ET | 9088 | 3.735 |
09:52 ET | 4419 | 3.745 |
09:54 ET | 4066 | 3.715 |
09:56 ET | 3408 | 3.72 |
09:57 ET | 3501 | 3.73 |
09:59 ET | 2217 | 3.75 |
10:01 ET | 10177 | 3.79 |
10:03 ET | 2963 | 3.7801 |
10:06 ET | 6236 | 3.7701 |
10:08 ET | 4581 | 3.76 |
10:10 ET | 7318 | 3.72 |
10:12 ET | 6742 | 3.69 |
10:14 ET | 4992 | 3.7 |
10:15 ET | 5286 | 3.685 |
10:17 ET | 1800 | 3.68 |
10:19 ET | 5200 | 3.685 |
10:21 ET | 1905 | 3.69 |
10:24 ET | 4152 | 3.66 |
10:26 ET | 3400 | 3.66 |
10:28 ET | 5002 | 3.68 |
10:30 ET | 1854 | 3.675 |
10:32 ET | 4595 | 3.68 |
10:33 ET | 4780 | 3.675 |
10:35 ET | 3002 | 3.665 |
10:37 ET | 3545 | 3.67 |
10:39 ET | 32154 | 3.68 |
10:42 ET | 39900 | 3.67 |
10:44 ET | 12483 | 3.67 |
10:46 ET | 8487 | 3.67 |
10:48 ET | 12906 | 3.68 |
10:50 ET | 4837 | 3.68 |
10:51 ET | 53862 | 3.665 |
10:53 ET | 67276 | 3.635 |
10:55 ET | 41350 | 3.6 |
10:57 ET | 15528 | 3.605 |
11:00 ET | 6281 | 3.595 |
11:02 ET | 12152 | 3.615 |
11:04 ET | 4227 | 3.61 |
11:06 ET | 8558 | 3.6 |
11:08 ET | 26367 | 3.615 |
11:09 ET | 19421 | 3.67 |
11:11 ET | 538834 | 3.645 |
11:13 ET | 27619 | 3.652 |
11:15 ET | 2833 | 3.665 |
11:18 ET | 7830 | 3.64 |
11:20 ET | 6118 | 3.66 |
11:22 ET | 16314 | 3.665 |
11:24 ET | 9174 | 3.655 |
11:26 ET | 12462 | 3.645 |
11:27 ET | 5240 | 3.645 |
11:29 ET | 8598 | 3.665 |
11:31 ET | 10643 | 3.645 |
11:33 ET | 1789 | 3.645 |
11:36 ET | 5729 | 3.665 |
11:38 ET | 2277 | 3.655 |
11:40 ET | 6754 | 3.655 |
11:42 ET | 22005 | 3.67 |
11:44 ET | 700 | 3.665 |
11:45 ET | 3929 | 3.66 |
11:47 ET | 2802 | 3.66 |
11:49 ET | 2800 | 3.66 |
11:51 ET | 4834 | 3.655 |
11:54 ET | 4484 | 3.675 |
11:56 ET | 5345 | 3.665 |
11:58 ET | 5281 | 3.66 |
12:00 ET | 3300 | 3.655 |
12:02 ET | 4442 | 3.665 |
12:03 ET | 4911 | 3.66 |
12:05 ET | 8863 | 3.675 |
12:07 ET | 4246 | 3.665 |
12:09 ET | 6841 | 3.66 |
12:12 ET | 8120 | 3.675 |
12:14 ET | 3214 | 3.66 |
12:16 ET | 30755 | 3.645 |
12:18 ET | 2943 | 3.645 |
12:20 ET | 1295 | 3.645 |
12:21 ET | 4928 | 3.645 |
12:23 ET | 11748 | 3.64 |
12:25 ET | 58623 | 3.66 |
12:27 ET | 3800 | 3.66 |
12:30 ET | 17483 | 3.66 |
12:32 ET | 5640 | 3.655 |
12:34 ET | 2500 | 3.655 |
12:36 ET | 2598 | 3.655 |
12:38 ET | 3286 | 3.66 |
12:39 ET | 2798 | 3.655 |
12:41 ET | 2330 | 3.66 |
12:43 ET | 2885 | 3.655 |
12:45 ET | 1783 | 3.655 |
12:48 ET | 52514 | 3.645 |
12:50 ET | 119114 | 3.6298 |
12:52 ET | 16567 | 3.58 |
12:54 ET | 4867 | 3.57 |
12:56 ET | 3069 | 3.57 |
12:57 ET | 31882 | 3.6 |
12:59 ET | 207595 | 3.6 |
01:01 ET | 14683 | 3.575 |
01:03 ET | 207747 | 3.585 |
01:06 ET | 10829 | 3.565 |
01:08 ET | 9133 | 3.57 |
01:10 ET | 1800 | 3.58 |
01:12 ET | 34001 | 3.565 |
01:14 ET | 1400 | 3.555 |
01:15 ET | 2400 | 3.565 |
01:17 ET | 61736 | 3.58 |
01:19 ET | 2666 | 3.58 |
01:21 ET | 4517 | 3.595 |
01:24 ET | 1165 | 3.59 |
01:26 ET | 6570 | 3.585 |
01:28 ET | 8252 | 3.5995 |
01:30 ET | 6551 | 3.61 |
01:32 ET | 5195 | 3.605 |
01:33 ET | 1298 | 3.61 |
01:35 ET | 14351 | 3.605 |
01:37 ET | 1592 | 3.6 |
01:39 ET | 3600 | 3.6 |
01:42 ET | 36003 | 3.605 |
01:44 ET | 1140 | 3.605 |
01:46 ET | 3761 | 3.615 |
01:48 ET | 2491 | 3.625 |
01:50 ET | 3783 | 3.6299 |
01:51 ET | 700 | 3.625 |
01:53 ET | 3359 | 3.615 |
01:55 ET | 4530 | 3.615 |
01:57 ET | 6055 | 3.615 |
02:00 ET | 3190 | 3.615 |
02:02 ET | 2452 | 3.615 |
02:04 ET | 2944 | 3.61 |
02:06 ET | 18108 | 3.635 |
02:08 ET | 4100 | 3.645 |
02:09 ET | 8351 | 3.65 |
02:11 ET | 4361 | 3.655 |
02:13 ET | 1200 | 3.66 |
02:15 ET | 933 | 3.655 |
02:18 ET | 3835 | 3.645 |
02:20 ET | 1211 | 3.645 |
02:22 ET | 2711 | 3.645 |
02:24 ET | 800 | 3.645 |
02:26 ET | 20176 | 3.645 |
02:27 ET | 5552 | 3.645 |
02:29 ET | 1661 | 3.64 |
02:31 ET | 11032 | 3.665 |
02:33 ET | 367 | 3.67 |
02:36 ET | 2070 | 3.66 |
02:38 ET | 1100 | 3.67 |
02:40 ET | 200 | 3.665 |
02:42 ET | 1695 | 3.665 |
02:44 ET | 940 | 3.665 |
02:45 ET | 1605 | 3.665 |
02:47 ET | 1200 | 3.66 |
02:49 ET | 1914 | 3.665 |
02:51 ET | 900 | 3.66 |
02:54 ET | 8442 | 3.645 |
02:56 ET | 12599 | 3.645 |
02:58 ET | 1676 | 3.645 |
03:00 ET | 1868 | 3.64 |
03:02 ET | 4300 | 3.645 |
03:03 ET | 400 | 3.65 |
03:05 ET | 900 | 3.65 |
03:07 ET | 37688 | 3.645 |
03:09 ET | 4379 | 3.645 |
03:12 ET | 24027 | 3.62 |
03:14 ET | 9841 | 3.64 |
03:16 ET | 1663 | 3.635 |
03:18 ET | 7427 | 3.64 |
03:20 ET | 400 | 3.635 |
03:21 ET | 1831 | 3.635 |
03:23 ET | 6312 | 3.6305 |
03:25 ET | 8439 | 3.64 |
03:27 ET | 17271 | 3.665 |
03:30 ET | 5230 | 3.655 |
03:32 ET | 1601 | 3.655 |
03:34 ET | 16843 | 3.655 |
03:36 ET | 2406 | 3.655 |
03:38 ET | 2916 | 3.66 |
03:39 ET | 3016 | 3.655 |
03:41 ET | 10935 | 3.665 |
03:43 ET | 4313 | 3.665 |
03:45 ET | 1864 | 3.665 |
03:48 ET | 11502 | 3.655 |
03:50 ET | 6731 | 3.65 |
03:52 ET | 5656 | 3.655 |
03:54 ET | 40991 | 3.655 |
03:56 ET | 52056 | 3.655 |
03:57 ET | 23120 | 3.655 |
03:59 ET | 431230 | 3.67 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fate Therapeutics Inc | 418.9M | -1.9x | --- |
Editas Medicine Inc | 427.6M | -2.6x | --- |
Contineum Therapeutics Inc | 394.1M | 20.7x | --- |
ADC Therapeutics SA | 329.9M | -1.2x | --- |
Poseida Therapeutics Inc | 289.9M | -2.6x | --- |
Adaptimmune Therapeutics PLC | 288.8M | -1.5x | --- |
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $418.9M |
---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.90 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 64.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.